Dropoetin 2000IU

PRODUCT CLASSIFICATION Glycoprotein Cytokine
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Drogsan
WAREHOUSE International Warehouse 2
ACTIVE SUBSTANCE Erythropoietin

Say hello to Dropoetin, your trusted solution for managing anemia associated with chronic renal failure. Approved for both pediatric and adult patients undergoing hemodialysis and peritoneal dialysis, Dropoetin is here to enhance your quality of life.

This powerful medication is also effective for adults experiencing severe renal-origin anemia symptoms, even if they haven't started dialysis yet. Additionally, Dropoetin plays a critical role in supporting adult cancer patients (excluding those with myeloid malignancies) undergoing chemotherapy by treating anemia and reducing the need for blood transfusions.

For adults living with HIV on zidovudine, Dropoetin is an essential treatment for anemia when endogenous levels are ?500 mU/ml. It also aids in autologous blood collection for patients with moderate anemia (hematocrits of 33-39%, hemoglobin of 10-13 g/dL) scheduled for major elective surgeries requiring significant blood volume, ensuring transfusion needs are minimized.

Dropoetin is also recommended for enhancing erythropoiesis during the surgical period, decreasing the likelihood of allogeneic blood transfusions, and addressing postoperative anemia in patients with moderate anemia who do not have access to autologous blood donation programs.

This medication is also indicated for treating anemia in patients with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS), specifically those with hemoglobin levels below 10 g/dL.

Always follow your physician's instructions when using Dropoetin. For specific dosing guidance, refer to the medication label. A Medication Guide is provided for patients, and it's crucial to read it thoroughly before each refill.

Dropoetin is typically administered via injection by a healthcare professional in a clinical setting. If you are using it at home, a healthcare provider will guide you on the correct usage. Make sure you fully understand the administration process and follow the training provided. If you have any questions, don't hesitate to contact your healthcare provider.

When preparing your dose, adhere to the techniques shown to you to prevent contamination of the vial, syringe, or medication. Avoid direct contact with the rubber stopper of the vial or the syringe needle.

Always double-check that you have drawn the correct dose before administration. Do not shake Dropoetin or use it if it has been shaken or frozen. Unless directed by your doctor, do not dilute Dropoetin or mix it with other solutions.

For single-dose vials, dispose of any leftover medication after administering your dose. If you have questions about single-dose vials, consult your healthcare provider.

Do not use Dropoetin if it appears cloudy, discolored, has particles, or if the vial is cracked or damaged. Keep Dropoetin, syringes, and needles out of reach of children and pets. Do not reuse needles or syringes, and consult your healthcare provider for proper disposal methods. Follow local regulations for disposal.

Continue your Dropoetin regimen even if you feel well, and do not skip doses. If you miss a dose, contact your doctor immediately.

For any questions regarding the use of Dropoetin, please reach out to your healthcare provider.

Serious adverse reactions are detailed in other sections of the label, including:

• Increased mortality, myocardial infarction, stroke, and thromboembolism
• Heightened risk of tumor progression or recurrence in cancer patients
• Hypertension
• Seizures
• Pure Red Cell Aplasia (PRCA)
• Severe allergic reactions